Zoetis, Inc. (ZTS)
77.10
-0.63
(-0.81%)
USD |
NYSE |
Aug 24, 16:00
77.45
+0.35
(+0.45%)
After-Hours: 20:00
Zoetis Debt to Equity Ratio : 2.935 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.935 |
| March 31, 2026 | 2.857 |
| December 31, 2025 | 2.791 |
| September 30, 2025 | 1.347 |
| June 30, 2025 | 1.364 |
| March 31, 2025 | 1.450 |
| December 31, 2024 | 1.426 |
| September 30, 2024 | 1.291 |
| June 30, 2024 | 1.358 |
| March 31, 2024 | 1.338 |
| December 31, 2023 | 1.361 |
| September 30, 2023 | 1.328 |
| June 30, 2023 | 1.458 |
| March 31, 2023 | 1.500 |
| December 31, 2022 | 1.846 |
| September 30, 2022 | 1.447 |
| June 30, 2022 | 1.470 |
| March 31, 2022 | 1.446 |
| December 31, 2021 | 1.493 |
| September 30, 2021 | 1.443 |
| June 30, 2021 | 1.688 |
| March 31, 2021 | 1.798 |
| December 31, 2020 | 1.964 |
| September 30, 2020 | 2.183 |
| June 30, 2020 | 2.632 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.417 |
| December 31, 2019 | 2.454 |
| September 30, 2019 | 2.483 |
| June 30, 2019 | 2.759 |
| March 31, 2019 | 2.853 |
| December 31, 2018 | 2.953 |
| September 30, 2018 | 3.041 |
| June 30, 2018 | 2.515 |
| March 31, 2018 | 2.528 |
| December 31, 2017 | 2.798 |
| September 30, 2017 | 2.867 |
| June 30, 2017 | 2.664 |
| March 31, 2017 | 2.777 |
| December 31, 2016 | 3.005 |
| September 30, 2016 | 2.818 |
| June 30, 2016 | 3.293 |
| March 31, 2016 | 3.835 |
| December 31, 2015 | 4.558 |
| September 30, 2015 | 2.957 |
| June 30, 2015 | 3.101 |
| March 31, 2015 | 2.852 |
| December 31, 2014 | 2.784 |
| September 30, 2014 | 2.677 |
| June 30, 2014 | 2.90 |
| March 31, 2014 | 3.396 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Merck & Co., Inc. | 1.286 |
| Elanco Animal Health, Inc. | 0.5947 |
| Boston Scientific Corp. | 0.5064 |
| Pfizer Inc. | 0.7418 |
| Phibro Animal Health Corp. | 2.176 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 15.08B |
| Total Liabilities (Quarterly) | 11.93B |
| Shareholders Equity (Quarterly) | 3.148B |
| Current Ratio | 3.084 |
| Net Debt Paydown Yield | -1.67% |